Product Name:4-Amino-3-phenylquinazolin-2(3H)-one

IUPAC Name:4-amino-3-phenyl-2,3-dihydroquinazolin-2-one

CAS:67461-76-1
Molecular Formula:C14H11N3O
Purity:97%
Catalog Number:CM216225
Molecular Weight:237.26

Packing Unit Available Stock Price($) Quantity
CM216225-1g 1-2 Weeks ɅǕƻ

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:67461-76-1
Molecular Formula:C14H11N3O
Melting Point:-
Smiles Code:O=C1N=C2C=CC=CC2=C(N)N1C3=CC=CC=C3
Density:
Catalog Number:CM216225
Molecular Weight:237.26
Boiling Point:
MDL No:
Storage:

Category Infos

Quinazolines
Quinazolines belong to heterocyclic chemistry, also known as 1,3-naphthalenes. The backbone consists of two six-membered aromatic rings fused to each other, with two nitrogen atoms at positions 1 and 3 on the backbone. The presence of these two nitrogen atoms in quinazoline increases its importance in pharmaceutical and biological reactions. Quinazolines and their derivatives are among the most important heterocyclic compounds due to their diverse chemical reactivity and important range of biological activities.

Related Products



Product Other Information

Product Overview 4-Amino-3-phenylquinazolin-2(3H)-one is a heterocyclic organic compound that has gained significant attention in the field of medicinal chemistry due to its potential therapeutic applications. This compound has been extensively studied for its biological activities, including its anticancer, antiviral, and antibacterial properties.
Synthesis and Application The most common method for synthesizing 4-Amino-3-phenylquinazolin-2(3H)-one is by reacting anthranilic acid with benzylidene acetone in the presence of a catalyst. Other methods include the reaction of anthranilic acid with 2-aminobenzophenone or 2-aminobenzaldehyde in the presence of a base. The yield of this compound is typically high, and the purity can be improved through recrystallization. 4-Amino-3-phenylquinazolin-2(3H)-one has been extensively studied for its potential therapeutic applications. It has been found to exhibit anticancer activity by inhibiting the growth of cancer cells and inducing apoptosis. Additionally, this compound has been found to possess antiviral properties and has been studied for its potential use in treating viral infections such as HIV and hepatitis B. Furthermore, it has been shown to exhibit antibacterial activity against various strains of bacteria, including Staphylococcus aureus and Escherichia coli.
Future Directions There are several future directions for the study of 4-Amino-3-phenylquinazolin-2(3H)-one. One potential direction is the development of more potent and selective analogs of this compound for use as anticancer or antiviral agents. Additionally, further studies are needed to fully understand the mechanism of action of this compound and its potential therapeutic applications. Finally, the use of this compound in combination with other drugs or therapies may enhance its efficacy and reduce potential toxicity.